1. 1) Ellman MH, Hurwitz H, Thomas C, et al. : Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 1741–1743, 1991.
2. 2) Gaulard P, Swerdlow SH, Harris NL, et al. : Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed by Swerdlow SH, Campo E, Harris NL, et al.). pp 350–351, IARC press, Lyon, 2008.
3. 4) Kameda T, Dobashi H, Miyatake N, et al. : Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 66: 1302–1309, 2014.
4. 5) Hoshida Y, Xu JX, Fujita S, et al. : Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322–331, 2007.
5. 10) Miranda RN, Loo E and Medeiros LJ : Iatrogenic immunodeficiency-associated classical Hodgkin lymphoma: clinicopathologic features of 54 cases reported in the literature. Am J Surg Pathol 37: 1895–1897, 2013.